{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T09:19:26Z","timestamp":1789118366806,"version":"build-2803163510"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"DOI":"10.1007\/s11926-026-01233-z","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T08:53:03Z","timestamp":1789116783000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Unraveling the Clinical Spectrum of DNASE1L3 Deficiency: Insights from Case Series and Systematic Literature Review"],"prefix":"10.1007","volume":"28","author":[{"given":"H\u00fclya","family":"Ercan Emreol","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilara","family":"Unal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erdal","family":"Sag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozge","family":"Ba\u015faran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yelda","family":"Bilginer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seza","family":"Ozen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,11]]},"reference":[{"key":"1233_CR1","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1001\/jama.2024.2315","volume":"331","author":"CH Siegel","year":"2024","unstructured":"Siegel CH, Sammaritano LR. Systemic lupus erythematosus: a review. Jama. 2024;331:1480\u201391. https:\/\/doi.org\/10.1001\/jama.2024.2315.","journal-title":"Jama"},{"key":"1233_CR2","doi-asserted-by":"publisher","unstructured":"Shiozawa, S. Pathogenesis of autoimmunity\/systemic lupus erythematosus (SLE). Cells. 2025;14. https:\/\/doi.org\/10.3390\/cells14141080.","DOI":"10.3390\/cells14141080"},{"key":"1233_CR3","doi-asserted-by":"publisher","unstructured":"Pagkopoulou E, et al. Autoantibodies in systemic lupus erythematosus: diagnostic and pathogenic insights. J Clin Med. 2025;14. https:\/\/doi.org\/10.3390\/jcm14165714.","DOI":"10.3390\/jcm14165714"},{"key":"1233_CR4","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.3389\/fimmu.2018.02496","volume":"9","author":"JM Alperin","year":"2018","unstructured":"Alperin JM, Ortiz-Fern\u00e1ndez L, Sawalha AH. Monogenic lupus: a developing paradigm of disease. Front Immunol. 2018;9:2496. https:\/\/doi.org\/10.3389\/fimmu.2018.02496.","journal-title":"Front Immunol"},{"key":"1233_CR5","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1546-0096-10-21","volume":"10","author":"A Belot","year":"2012","unstructured":"Belot A, Cimaz R. Monogenic forms of systemic lupus erythematosus: new insights into SLE pathogenesis. Pediatr Rheumatol Online J. 2012;10:21. https:\/\/doi.org\/10.1186\/1546-0096-10-21.","journal-title":"Pediatr Rheumatol Online J"},{"key":"1233_CR6","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1097\/bor.0000000000001008","volume":"36","author":"Y Qin","year":"2024","unstructured":"Qin Y, Ma J, Vinuesa CG. Monogenic lupus: insights into disease pathogenesis and therapeutic opportunities. Curr Opin Rheumatol. 2024;36:191\u2013200. https:\/\/doi.org\/10.1097\/bor.0000000000001008.","journal-title":"Curr Opin Rheumatol"},{"key":"1233_CR7","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1038\/ng.975","volume":"43","author":"SM Al-Mayouf","year":"2011","unstructured":"Al-Mayouf SM, et al. Loss-of-function variant in DNASE1L3 causes a familial form of systemic lupus erythematosus. Nat Genet. 2011;43:1186\u20138. https:\/\/doi.org\/10.1038\/ng.975.","journal-title":"Nat Genet"},{"key":"1233_CR8","doi-asserted-by":"publisher","first-page":"4331","DOI":"10.1093\/rheumatology\/keae679","volume":"64","author":"R Abdwani","year":"2025","unstructured":"Abdwani R, Mal MJ, Al Masroori E, Jaju S, Al Abrawi S. A deep dive into monogenic lupus: insights on DNASE1L3 mutation. Rheumatology (Oxford). 2025;64:4331\u20134. https:\/\/doi.org\/10.1093\/rheumatology\/keae679.","journal-title":"Rheumatology (Oxford)"},{"key":"1233_CR9","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1177\/0961203316676382","volume":"26","author":"A Carbonella","year":"2017","unstructured":"Carbonella A, et al. An autosomal recessive DNASE1L3-related autoimmune disease with unusual clinical presentation mimicking systemic lupus erythematosus. Lupus. 2017;26:768\u201372. https:\/\/doi.org\/10.1177\/0961203316676382.","journal-title":"Lupus"},{"key":"1233_CR10","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1002\/art.38010","volume":"65","author":"ZB Oz\u00e7akar","year":"2013","unstructured":"Oz\u00e7akar ZB, et al. DNASE1L3 mutations in hypocomplementemic urticarial vasculitis syndrome. Arthritis Rheum. 2013;65:2183\u20139. https:\/\/doi.org\/10.1002\/art.38010.","journal-title":"Arthritis Rheum"},{"key":"1233_CR11","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.3899\/jrheum.171358","volume":"45","author":"ED Batu","year":"2018","unstructured":"Batu ED, et al. Whole exome sequencing in early-onset systemic lupus erythematosus. J Rheumatol. 2018;45:1671\u20139. https:\/\/doi.org\/10.3899\/jrheum.171358.","journal-title":"J Rheumatol"},{"key":"1233_CR12","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1177\/09612033241255011","volume":"33","author":"S Sener","year":"2024","unstructured":"Sener S, et al. Detection of genetic mutations underlying early-onset systemic lupus erythematosus. Lupus. 2024;33:998\u20131003. https:\/\/doi.org\/10.1177\/09612033241255011.","journal-title":"Lupus"},{"key":"1233_CR13","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. https:\/\/doi.org\/10.1136\/bmj.n71.","journal-title":"BMJ"},{"key":"1233_CR14","doi-asserted-by":"publisher","first-page":"104262","DOI":"10.1016\/j.ejmg.2021.104262","volume":"64","author":"RM Kisla Ekinci","year":"2021","unstructured":"Kisla Ekinci RM, Balci S, Ozcan D, Atmis B, Bisgin A. Monogenic lupus due to DNASE1L3 deficiency in a pediatric patient with urticarial rash, hypocomplementemia, pulmonary hemorrhage, and immune-complex glomerulonephritis. Eur J Med Genet. 2021;64:104262. https:\/\/doi.org\/10.1016\/j.ejmg.2021.104262.","journal-title":"Eur J Med Genet"},{"key":"1233_CR15","doi-asserted-by":"publisher","first-page":"6432","DOI":"10.1093\/rheumatology\/keaf459","volume":"64","author":"C Triaille","year":"2025","unstructured":"Triaille C, et al. Early-onset systemic lupus erythematosus-ANCA-associated vasculitis overlap syndrome caused by DNASE1L3 deficiency. Rheumatology (Oxford). 2025;64:6432\u20134. https:\/\/doi.org\/10.1093\/rheumatology\/keaf459.","journal-title":"Rheumatology (Oxford)"},{"key":"1233_CR16","doi-asserted-by":"publisher","first-page":"e13162","DOI":"10.1111\/sji.13162","volume":"95","author":"D Gezgin Y\u0131ld\u0131r\u0131m","year":"2022","unstructured":"Gezgin Y\u0131ld\u0131r\u0131m D, Bakkalo\u011flu SA. Monogenic lupus caused by mutations in DNASE1L3: a rare cause of systemic lupus erythematosus in children. Scand J Immunol. 2022;95:e13162. https:\/\/doi.org\/10.1111\/sji.13162.","journal-title":"Scand J Immunol"},{"key":"1233_CR17","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2024-001477","author":"N Aljaberi","year":"2025","unstructured":"Aljaberi N, et al. Identification and functional characterisation of a novel DNASE1L3 variant (c.572A>G, p.Asn191Ser) in three Emirati families with systemic lupus erythematosus and hypocomplementaemic urticarial vasculitis. Lupus Sci Med. 2025. https:\/\/doi.org\/10.1136\/lupus-2024-001477.","journal-title":"Lupus Sci Med"},{"key":"1233_CR18","doi-asserted-by":"publisher","first-page":"e452","DOI":"10.1097\/mph.0000000000001780","volume":"43","author":"A Pa\u00e7 Kisaarslan","year":"2021","unstructured":"Pa\u00e7 Kisaarslan A, et al. Refractory and fatal presentation of severe autoimmune hemolytic anemia in a child with the DNASE1L3 mutation complicated with an additional DOCK8 variant. J Pediatr Hematol Oncol. 2021;43:e452\u20136. https:\/\/doi.org\/10.1097\/mph.0000000000001780.","journal-title":"J Pediatr Hematol Oncol"},{"key":"1233_CR19","doi-asserted-by":"publisher","first-page":"3109","DOI":"10.1007\/s10067-025-07509-6","volume":"44","author":"\u00d6 Ta\u015f","year":"2025","unstructured":"Ta\u015f \u00d6, Ayd\u0131n F, \u00d6z\u00e7akar ZB. Treatment and long-term follow-up of pediatric patients with hypocomplementemic urticarial vasculitis syndrome (HUVS): a case-based review. Clin Rheumatol. 2025;44:3109\u201318. https:\/\/doi.org\/10.1007\/s10067-025-07509-6.","journal-title":"Clin Rheumatol"},{"key":"1233_CR20","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12969-026-01203-w","volume":"24","author":"C Bianchi","year":"2026","unstructured":"Bianchi C, et al. Childhood-onset hypocomplementaemic urticarial vasculitis in France: phenotypic and genotypic diversity in 10 children. Pediatr Rheumatol. 2026;24:20. https:\/\/doi.org\/10.1186\/s12969-026-01203-w.","journal-title":"Pediatr Rheumatol"},{"key":"1233_CR21","doi-asserted-by":"publisher","first-page":"e70184","DOI":"10.1002\/acr2.70184","volume":"8","author":"AA Leon Tenorio","year":"2026","unstructured":"Leon Tenorio AA, et al. DNASE1L3 deficiency with novel missense variant: enzymatic and plasma fragmentomic evidence of pathogenicity and partial response to JAK blockade. ACR Open Rheumatol. 2026;8:e70184. https:\/\/doi.org\/10.1002\/acr2.70184.","journal-title":"ACR Open Rheumatol"},{"key":"1233_CR22","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaf631","author":"M Sharma","year":"2026","unstructured":"Sharma M, et al. Genetic landscape of early-onset systemic lupus erythematous in India. Rheumatology (Oxford). 2026. https:\/\/doi.org\/10.1093\/rheumatology\/keaf631.","journal-title":"Rheumatology (Oxford)"},{"key":"1233_CR23","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1007\/s10875-022-01287-5","volume":"42","author":"M Tusseau","year":"2022","unstructured":"Tusseau M, et al. DNASE1L3 deficiency, new phenotypes, and evidence for a transient type I IFN signaling. J Clin Immunol. 2022;42:1310\u201320. https:\/\/doi.org\/10.1007\/s10875-022-01287-5.","journal-title":"J Clin Immunol"},{"key":"1233_CR24","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1053\/j.ajkd.2024.05.014","volume":"84","author":"S Volpi","year":"2024","unstructured":"Volpi S, et al. Lupus nephritis patterns and response to type I interferon in patients with DNASE1L3 variants: report of three cases. Am J Kidney Dis. 2024;84:791\u20137. https:\/\/doi.org\/10.1053\/j.ajkd.2024.05.014.","journal-title":"Am J Kidney Dis"},{"key":"1233_CR25","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1056\/NEJMc2601997","volume":"395","author":"T Av\u010din","year":"2026","unstructured":"Av\u010din T, et al. Targeted degradation of NETs in lupus with DNASE1L3 deficiency. N Engl J Med. 2026;395:308\u201310. https:\/\/doi.org\/10.1056\/NEJMc2601997.","journal-title":"N Engl J Med"},{"key":"1233_CR26","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2025-001918","author":"SM Al-Mayouf","year":"2026","unstructured":"Al-Mayouf SM, et al. Genetic and phenotypic landscape of monogenic lupus: insights from an international cohort. Lupus Sci Med. 2026. https:\/\/doi.org\/10.1136\/lupus-2025-001918.","journal-title":"Lupus Sci Med"},{"key":"1233_CR27","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s10238-025-02008-z","volume":"26","author":"X Liu","year":"2025","unstructured":"Liu X, Yu Y, Cai S, Dong L. The role of DNASE1L3 in systemic lupus erythematosus: from pathogenesis to clinical implications. Clin Exp Med. 2025;26:71. https:\/\/doi.org\/10.1007\/s10238-025-02008-z.","journal-title":"Clin Exp Med"},{"key":"1233_CR28","doi-asserted-by":"publisher","first-page":"e99","DOI":"10.1016\/s2665-9913(19)30142-0","volume":"2","author":"A Belot","year":"2020","unstructured":"Belot A, et al. Contribution of rare and predicted pathogenic gene variants to childhood-onset lupus: a large, genetic panel analysis of British and French cohorts. Lancet Rheumatol. 2020;2:e99\u2013109. https:\/\/doi.org\/10.1016\/s2665-9913(19)30142-0.","journal-title":"Lancet Rheumatol"},{"key":"1233_CR29","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s11926-016-0621-9","volume":"18","author":"MS Lo","year":"2016","unstructured":"Lo MS. Monogenic lupus. Curr Rheumatol Rep. 2016;18:71. https:\/\/doi.org\/10.1007\/s11926-016-0621-9.","journal-title":"Curr Rheumatol Rep"},{"key":"1233_CR30","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.coi.2017.10.008","volume":"49","author":"P Costa-Reis","year":"2017","unstructured":"Costa-Reis P, Sullivan KE. Monogenic lupus: it\u2019s all new! Curr Opin Immunol. 2017;49:87\u201395. https:\/\/doi.org\/10.1016\/j.coi.2017.10.008.","journal-title":"Curr Opin Immunol"},{"key":"1233_CR31","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1084\/jem.20161596","volume":"213","author":"MP Rodero","year":"2016","unstructured":"Rodero MP, Crow YJ. Type I interferon-mediated monogenic autoinflammation: the type I interferonopathies, a conceptual overview. J Exp Med. 2016;213:2527\u201338. https:\/\/doi.org\/10.1084\/jem.20161596.","journal-title":"J Exp Med"},{"key":"1233_CR32","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1146\/annurev-pathol-020117-043952","volume":"14","author":"MK Crow","year":"2019","unstructured":"Crow MK, Olferiev M, Kirou KA. Type I interferons in autoimmune disease. Annu Rev Pathol. 2019;14:369\u201393. https:\/\/doi.org\/10.1146\/annurev-pathol-020117-043952.","journal-title":"Annu Rev Pathol"},{"key":"1233_CR33","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20201138","author":"J Hartl","year":"2021","unstructured":"Hartl J, et al. Autoantibody-mediated impairment of DNASE1L3 activity in sporadic systemic lupus erythematosus. J Exp Med. 2021. https:\/\/doi.org\/10.1084\/jem.20201138.","journal-title":"J Exp Med"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-026-01233-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11926-026-01233-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-026-01233-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T08:53:04Z","timestamp":1789116784000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11926-026-01233-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,11]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1233"],"URL":"https:\/\/doi.org\/10.1007\/s11926-026-01233-z","relation":{},"ISSN":["1534-6307"],"issn-type":[{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,11]]},"assertion":[{"value":"24 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted in accordance with the principles of the Declaration of Helsinki. Ethical approval for this study was obtained from the Hacettepe University Ethics Committee. Written informed consent for publication of clinical data was obtained from the patients\u2019 parents or legal guardians.","order":1,"name":"Ethics","label":"Ethics Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflicts of interest relevant to this work.","order":2,"name":"Ethics","label":"Competing interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"26"}}